UnitedHealth Raises Guidance, but a $610 Million Reserve Benefit Matters

UnitedHealth Group reported third-quarter adjusted earnings of $4.69 per share and raised its 2026 adjusted earnings outlook to at least $20.50. The results showed meaningful improvement, but one item deserves separation from the underlying trend: $610 million of favorable prior-period reserve development.

The medical care ratio, the share of insurance premiums used for medical costs, improved to 88.4% from 89.9% a year earlier. Releasing reserves means earlier estimates for claims proved higher than the amounts ultimately needed. That is positive, but it is not automatically repeatable. The cleaner test is whether current-period medical costs and pricing also improve.

Optum Health provided another source of recovery. Operating earnings rose to $735 million from $41 million a year earlier after UnitedHealth exited value-based care markets where it lacked sufficient scale. Revenue in the unit fell, showing that management accepted a smaller footprint to improve profitability. Optum Insight and Optum Rx also increased operating earnings.

The tradeoff appears in membership. UnitedHealthcare medical membership declined to 48.3 million from 50.1 million a year earlier, with pressure in Medicare Advantage and Medicaid. Total company revenue slipped 0.4% to $112.69 billion, even as earnings exceeded expectations. Stronger margins are valuable, but a durable turnaround eventually needs stable enrollment or growth.

UnitedHealth’s official release also reported $5.1 billion of operating cash flow and a 41.7% debt-to-capital ratio at September 30. Investors should compare future medical care ratios with and without reserve effects, track membership and examine whether Optum’s margin repair continues. The raised outlook is real; the unanswered question is how much of the quarter can recur.